Measures · D07 in 2020 · Part D · DD3 Member Experience with the Drug Plan
Rating of Drug Plan
Drug PlanMember ExperienceSource: CAHPS
- What it measures
- Percent of the best possible score the plan earned from members who rated the prescription drug plan.
- How it's calculated
- This case-mix adjusted measure is used to assess members' overall view of their prescription drug plan. The Consumer Assessment of Healthcare Providers and Systems (CAHPS) score uses the mean of the distribution of responses converted to a scale from 0 to 100. The score shown is the percentage of the best possible score each contract earned.
- Data source
- CAHPS CAHPS Survey Questions (question numbers vary depending on survey type): • Using any number from 0 to 10, where 0 is the worst prescription drug plan possible and 10 is the best prescription drug plan possible, what number would you use to rate your prescription drug plan?
- Measurement period
- 03/2019 – 05/2019
- Better when
- Higher
- Weight
- 1.5 (Patients’ Experience and Complaints Measure)
- Star assignment
- Relative Distribution and Significance Testing
- Case-mix adjusted
- —
- In improvement measure
- Yes
- Used in CAI
- No
- Notes
- CAHPS Survey results were sent to each contract's Medicare Compliance Officer in August 2019. These reports provide further explanation of the CAHPS scoring methodology and provide detailed information on why a specific rating was assigned.
- Disaster policy
- Higher measure star (2019-2020) for contracts with 25% or more enrolled affected by 2018 disasters. No adjustment for 2017 disasters, because measurement period after 2017 disasters.
From the 2020 Star Ratings Technical Notes (CMS).
Cut points over time
Score needed to earn each star level. Part D thresholds differ for MA-PD and standalone PDP contracts. Dotted lines and open dots: where the cut points may move for 2028.
How the 2028 cut points are projected
Each boundary moves by its median year-on-year change since 2019. It's the same projection the Star outlook uses for every contract. CMS sets real cut points from all contracts' scores each year, so treat these as a direction, not a forecast of the exact number.
| Stars | Org type | 2027 | Projected 2028 | Move |
|---|---|---|---|---|
| 2★ | MA-PD | 84 | 85 | +1 |
| 3★ | MA-PD | 86 | 86 | 0 |
| 4★ | MA-PD | 87 | 87 | 0 |
| 5★ | MA-PD | 89 | 89 | 0 |
| 2★ | PDP | 82 | 82 | 0 |
| 3★ | PDP | 83 | 83 | 0 |
| 4★ | PDP | 86 | 86 | 0 |
| 5★ | PDP | 88 | 88 | 0 |
2020 star distribution
Not rated: Plan too new to be measured (165); Plan too small to be measured (114); Plan not required to report measure (10); Not enough data available (5)
Cut point bands
| Star year | Org type | 1★ | 2★ | 3★ | 4★ | 5★ |
|---|---|---|---|---|---|---|
| 2027 | MA-PD | < 84 | >= 84 to < 86 | >= 86 to < 87 | >= 87 to < 89 | >= 89 |
| 2027 | PDP | < 82 | >= 82 to < 83 | >= 83 to < 86 | >= 86 to < 88 | >= 88 |
| 2026 | MA-PD | < 85 | >= 85 to < 86 | >= 86 to < 88 | >= 88 to < 89 | >= 89 |
| 2026 | PDP | < 82 | >= 82 to < 83 | >= 83 to < 86 | >= 86 to < 88 | >= 88 |
| 2025 | MA-PD | < 84 | >= 84 to < 86 | >= 86 to < 87 | >= 87 to < 89 | >= 89 |
| 2025 | PDP | < 79 | >= 79 to < 82 | >= 82 to < 85 | >= 85 to < 87 | >= 87 |
| 2024 | MA-PD | < 84 | >= 84 to < 85 | >= 85 to < 87 | >= 87 to < 89 | >= 89 |
| 2024 | PDP | < 80 | >= 80 to < 81 | >= 81 to < 83 | >= 83 to < 87 | >= 87 |
| 2023 | MA-PD | < 83 | >= 83 to < 85 | >= 85 to < 87 | >= 87 to < 88 | >= 88 |
| 2023 | PDP | < 79 | >= 79 to < 80 | >= 80 to < 83 | >= 83 to < 87 | >= 87 |
| 2022 | MA-PD | < 84 | >= 84 to < 85 | >= 85 to < 87 | >= 87 to < 88 | >= 88 |
| 2022 | PDP | < 80 | >= 80 to < 82 | >= 82 to < 84 | >= 84 to < 87 | >= 87 |
| 2021 | MA-PD | < 83 | >= 83 to < 84 | >= 84 to < 86 | >= 86 to < 87 | >= 87 |
| 2021 | PDP | < 80 | >= 80 to < 81 | >= 81 to < 83 | >= 83 to < 87 | >= 87 |
| 2020 | MA-PD | < 83 | ? 83 to < 84 | ? 84 to < 86 | ? 86 to < 87 | ? 87 |
| 2020 | PDP | < 80 | ? 80 to < 81 | ? 81 to < 83 | ? 83 to < 87 | ? 87 |
| 2019 | MA-PD | < 82 | ? 82 to < 83 | ? 83 to < 85 | ? 85 to < 87 | ? 87 |
| 2019 | PDP | < 80 | ? 80 to < 81 | ? 81 to < 84 | ? 84 to < 86 | ? 86 |
| 2018 | MA-PD | < 81 | ? 81 to < 83 | ? 83 to < 85 | ? 85 to < 86 | ? 86 |
| 2018 | PDP | < 80 | ? 80 to < 81 | ? 81 to < 83 | ? 83 to < 87 | ? 87 |
| 2017 | MA-PD | < 80 | ? 80 to < 82 | ? 82 to < 84 | ? 84 to < 86 | ? 86 |
| 2017 | PDP | < 79 | ? 79 to < 80 | ? 80 to < 83 | ? 83 to < 86 | ? 86 |
| 2016 | MA-PD | < 80 | ? 80 to < 82 | ? 82 to < 84 | ? 84 to < 86 | ? 86 |
| 2016 | PDP | < 80 | ? 80 to < 81 | ? 81 to < 82 | ? 82 to < 86 | ? 86 |
| 2015 | MA-PD | < 82% | ? 82% to < 83% | ? 83% to < 84% | ? 84% to < 87% | ? 87% |
| 2015 | PDP | < 80% | ? 80% to < 81% | * | ? 81% to < 86% | ? 86% |
Lowest-scoring contracts, 2020
| Contract | Parent | Members | Score | Stars | Δ | Shortfall to 4★ | Pctile |
|---|---|---|---|---|---|---|---|
| S6986 Mii Life Insurance, Incorporated | Aware Integrated, Inc. | — | 75 | 1 | 0 | 8 | 0% |
| H0351 Wellcare | Centene Corporation | 23,066 | 77 | 1 | 0 | 9 | 0% |
| H3206 Presbyterian Insurance Company, Inc. | Presbyterian Healthcare Services | — | 78 | 1 | 0 | 8 | 0% |
| H1894 Wellpoint | Elevance Health, Inc. | 2,322 | 78 | 1 | 0 | 8 | 0% |
| H4213 Arkansas Blue Medicare | USAble Mutual Insurance Company | 2,258 | 78 | 1 | 0 | 8 | 0% |
| H5439 Wellcare | Centene Corporation | 19,153 | 78 | 1 | — | 8 | 0% |
| H3342 Anthem Blue Cross and Blue Shield | Elevance Health, Inc. | — | 79 | 1 | −3 | 7 | 1% |
| H8432 Anthem Blue Cross and Blue Shield HP | Elevance Health, Inc. | 43,447 | 79 | 1 | −3 | 7 | 1% |
| H3813 Moda Health Plan, Inc. | Moda Partners, Inc. | — | 79 | 1 | −2 | 7 | 1% |
| H3307 UnitedHealthcare | UnitedHealth Group, Inc. | — | 79 | 1 | 0 | 7 | 1% |
| S6506 Blue Cross Blue Shield of Arizona (AZ Blue) | Blue Cross Blue Shield of Arizona | — | 78 | 1 | −1 | 5 | 2% |
| S5904 Florida Blue | Guidewell Mutual Holding Corporation | 46,802 | 78 | 1 | −1 | 5 | 2% |
| H5434 Florida Blue | Guidewell Mutual Holding Corporation | 61,748 | 80 | 1 | −2 | 6 | 2% |
| H9276 Allwell | Centene Corporation | — | 80 | 1 | — | 6 | 2% |
| E0654 TEAMStar Medicare Part D Prescription Drug Program | IBT Voluntary Employee Benefits Trust | — | 80 | 2 | −1 | 6 | 2% |
| H0107 Blue Cross and Blue Shield of Montana | Health Care Service Corporation | 102,207 | 80 | 1 | 0 | 6 | 2% |
| H5009 Regence BlueShield | Cambia Health Solutions, Inc. | 10,384 | 80 | 1 | 0 | 6 | 2% |
| H3312 Aetna Medicare | CVS Health Corporation | 105,069 | 80 | 1 | 0 | 6 | 2% |
| H3979 Blue Cross and Blue Shield of Oklahoma | Health Care Service Corporation | 3,163 | 80 | 1 | 0 | 6 | 2% |
| H2773 Quality Health Plans Of New York, Inc. | QHP Financial Group, Inc. | — | 80 | 1 | −2 | 6 | 2% |
| H7245 Premera Blue Cross Medicare Advantage | Premera | — | 80 | 1 | 0 | 6 | 2% |
| H6743 ATRIO Health Plans | ATRIO Health Plans | 21,042 | 80 | 1 | −1 | 6 | 2% |
| H1666 Blue Cross and Blue Shield of NM, TX | Health Care Service Corporation | 15,741 | 80 | 1 | 0 | 6 | 2% |
| H8764 Aspire Health | Montage Health | 8,379 | 81 | 1 | −2 | 5 | 5% |
| H9699 Arkansas Blue Medicare | USAble Mutual Insurance Company | 7,909 | 81 | 1 | −1 | 5 | 5% |
History
| Star year | Code | Name | Measured | Weight | Source |
|---|---|---|---|---|---|
| 2027 | D05 | Rating of Drug Plan | 03/2026 – 06/2026 | 2 | CAHPS |
| 2026 | D05 | Rating of Drug Plan | 03/2025 – 05/2025 | 2 | CAHPS |
| 2025 | D05 | Rating of Drug Plan | 03/2024 – 06/2024 | 4 | CAHPS |
| 2024 | D05 | Rating of Drug Plan | 03/2023 – 06/2023 | 4 | CAHPS |
| 2023 | D05 | Rating of Drug Plan | 03/2022 – 06/2022 | 4 | CAHPS |
| 2022 | D05 | Rating of Drug Plan | 03/2021 – 05/2021 | 2 | CAHPS |
| 2021 | D07 | Rating of Drug Plan | 03/2019 – 05/2019 | 2 | CAHPS |
| 2020 | D07 | Rating of Drug Plan | 03/2019 – 05/2019 | 1.5 | CAHPS |
| 2019 | D07 | Rating of Drug Plan | 03/2018 – 06/2018 | 1.5 | CAHPS |
| 2018 | D08 | Rating of Drug Plan | 03/2017 – 06/2017 | 1.5 | CAHPS |
| 2017 | D08 | Rating of Drug Plan | 02/2016 – 08/2016 | 1.5 | CAHPS |
| 2016 | D08 | Rating of Drug Plan | 02/15/2015 - 05/31/2015 | 1.5 | CAHPS |
| 2015 | D06 | Rating of Drug Plan | 02/15/2014 - 05/31/2014 | 1.5 | CAHPS |